Neurologist and clinician scientist with a basic, translational and clinical research program, focused mostly on stroke and other brain injuries. The laboratory utilizes a variety of cell free, tissue culture and in-vivo techniques to design and characterize a series of carbon nanomaterials that possess the ability to act as catalytic antioxidants as well as support key mitochondrial functions. This NIH-supported research is in collaboration with synthetic nano-chemists at Rice University (Tour Lab) and biochemists at University of Texas Health Science Center Houston (Tsai Lab). The group is testing a variety of engineered modifications of these versatile, non-toxic materials to address specific cell injury and death mechanisms including ferroptosis and interruption in electron transport and oxidative phosphorylation.
A major interest of ours is the role of diabetes in worsening outcome from stroke, a condition that affects minority and rural Texans disproportionally. With a range of research from molecular interactions to whole animal and clinical studies, the work in this lab is deeply translational, leveraging the group's clinical training and experience to insure that conclusions have direct relevance to the disease state, with the ultimate goal of facilitating the identification of new therapies for these major contributors to disability and mortality.
- Mandel, J. J., Yust-Katz, S., Patel, A. J., Cachia, D., Liu, D., Park, M., ... de Groot, J. F. (2018). Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.. Neuro-Oncology. 20(1), 113-122.
- Derry, P. J., & Kent, T. A. (2017). Correlating quantitative susceptibility mapping with cognitive decline in Alzheimer's disease.. Brain. 140(8), 2069-2072.
- Zhu, Y., Gao, X., Ni, Y., Li, W., Kent, T. A., Qiao, S., ... Zhang, H. (2017). Sevoflurane postconditioning attenuates reactive astrogliosis and glial scar formation after ischemia–reperfusion brain injury. NEUROSCIENCE. 356, 125-141.
- Miles, S. R., Sharp, C., Tharp, A. T., Stanford, M. S., Stanley, M., Thompson, K. E., & Kent, T. A. (2017). Emotion dysregulation as an underlying mechanism of impulsive aggression: Reviewing empirical data to inform treatments for veterans who perpetrate violence. Aggression and Violent Behavior. 34, 147-153.
- Zhou, X., Luo, Y. u., Zhu, Y., Liu, Z., Kent, T. A., Rong, J., ... Zhang, H. (2017). Inhibition of autophagy blocks cathepsins–tBid–mitochondrial apoptotic signaling pathway via stabilization of lysosomal membrane in ischemic astrocytes. CELL DEATH & DISEASE. 8(2), e2618-e2618.
- Martini, S. R., & Kent, T. A. (2016). Cerebrovascular disease. Neurology Secrets: Sixth Edition. (pp. 222-233). Elsevier.
- Martini, S. R., & Kent, T. A. (2013). Stroke and Transient Ischemic Attack. Cardiology Secrets: Fourth Edition. (pp. 433-443). Elsevier.
- Mandava, P., Krumpelman, C. S., Murthy, S. B., & Kent, T. A. (2012). A Critical Review of Stroke Trial Analytical Methodology: Outcome Measures, Study Design, and Correction for Imbalances. Translational Stroke Research. (pp. 833-861). Springer New York.
- Martini, S. R., & Kent, T. A. (2010). Stroke and TIA. Cardiology Secrets. (pp. 355-362). Elsevier.
- Mitra, J., Dharmalingam, P., Talakatta, G., Wang, H., Derry, P. J., Vasquez, V., ... Hegde, M. L. (2020). Pervasive Hemin-Induced Genome Toxicity in Experimental Intracerebral Hemorrhage (ICH): Implications and Therapeutic Interventions.. Environ Mol Mutagen. 61, 58-58.
- Derry, P. J., McHugh, E. A., Liopo, A. V., Tour, J. M., & Kent, T. A. (2019). A novel, injectable carbon nanoparticle demonstrates electron shuttling capabilities: a potential therapeutic \"nanozyme'' for mitochondrial protection in ischemic injury. Journal of Cerebral Blood Flow & Metabolism. 39, 367-367.
- Anderson, J. A., Kimmel, B., Xiaohui, T., Ovalle, A., Ifeorah, C., Gina, E., Nwangwa, D., & Kent, T. A. (2019). Mobile Health mHealth for Secondary Stroke Prevention is Feasible and Effective.. STROKE. 50,
- Mendoza, K., Cherian, L., Nilewski, L., Tour, J. M., Kent, T. A., & Robertson, C. S. (2018). A NEW CLASS OF CARBON ANTIOXIDANTS RESTORED CEREBRAL PERFUSION IN TRAUMATIC BRAIN INJURY COMPLICATED BY SYSTEMIC HYPOTENSION. Journal of Neurotrauma. 35(16), A5-A5.
- Mendoza, K., Cherian, L., Nilewski, L., Tour, J. M., Kent, T. A., & Robertson, C. S. (2018). A NEW CLASS OF CARBON ANTIOXIDANTS RESTORED CEREBRAL PERFUSION IN TRAUMATIC BRAIN INJURY COMPLICATED BY SYSTEMIC HYPOTENSION. Journal of Neurotrauma. 35(16), A21-A21.